XRN

Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total revenue 35.16 M34.62 M37.97 M37.23 M38.39 M 148.21 M Gross profit 35.16 M34.62 M37.97 M37.23 M38.39 M 148.21 M Operating expenses 18.77 M15.05 M18.56 M17.17 M18.84 M 69.63 M Selling/general/admin expenses 7.71 M3.62 M6.03 M4.86 M5.49 M 20 M Research & development ————— — Operating income 16.39 M19.57 M19.41 M20.05 M19.55 M 78.58 M Non-Operating Income, Total ————— — Interest expense, net of interest capitalized 7.57 M7.17 M8.01 M8.18 M8.4 M 31.75 M Non-Operating Income, excl. Interest Expenses ————— — Unusual income/expense ————— — Pretax income 23.58 M27.15 M27.63 M28.28 M28.14 M 111.2 M Equity in earnings ————— — Taxes ————— — Non-controlling/minority interest 109 K178 K-70 K-512 K-643 K -1.05 M After tax other income/expense -7 000-25 K-45 K-24 K-53 K -147 K Net income before discontinued operations -2.83 M2.38 M378 K-5.35 M-5.78 M -8.37 M Discontinued operations 5.76 M1.36 M207 K294 K-372 K 1.49 M Net income 2.94 M3.74 M585 K-5.06 M-6.15 M -6.88 M Dilution adjustment -109 K-178 K70 K512 K643 K 1.05 M Preferred dividends 1.46 M1.46 M1.46 M1.46 M1.92 M 6.28 M Diluted net income available to common stockholders 1.37 M2.1 M-800 K-6 M-7.42 M -12.12 M Basic earnings per share (Basic EPS) 0.110.15-0.05-0.45-0.56 -0.91 Diluted earnings per share (Diluted EPS) 0.110.15-0.05-0.45-0.56 -0.91 Average basic shares outstanding 13.19 M13.37 M13.38 M13.39 M13.38 M 53.52 M Diluted shares outstanding 13.19 M13.37 M13.38 M13.39 M13.38 M 53.52 M EBITDA 30.02 M33.39 M34.7 M35.06 M34.46 M 137.62 M EBIT 16.39 M19.57 M19.41 M20.05 M19.55 M 78.58 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 13.64 M13.83 M15.29 M15.01 M14.92 M 59.04 M